Rheumatology Department, CHU Rennes.
U1241, CIMIAD Unit, INSERM.
Rheumatology (Oxford). 2021 May 14;60(5):2238-2245. doi: 10.1093/rheumatology/keaa567.
To establish a new predictive score for the diagnosis of septic arthritis (SA) according to different synovial fluid (SF) variables.
First, we analysed the different clinical, biological and SF variables associated with the diagnosis of SA (according to the Newman's criteria) in a monocentric cohort of acute arthritis (<30 days) (n = 233) (SYNOLACTATE cohort). A new score predictive of SA (RESAS) was created using the independent discriminant variables after multivariate analysis. A value was attributed to each variable of the score according to the weighting based on their likelihood ratio for the diagnosis of SA. RESAS performance was then tested on the first cohort (internal validation) and then checked on a second independent cohort (n = 70) (external validation).
After multivariate analysis, four independent variables of the SF were included for RESAS: (i) purulent SF or white blood cells count ≥70 000/mm3; (ii) absence/presence of crystals; (iii) lactate; and (iv) glucose synovial level. RESAS ranged between -4 and +13 points. The performance of RESAS to predicted SA was excellent with area under the curve (AUC)=0.928 (0.877-0.980) in internal validation and AUC=0.986 (0.962-1.00) in external validation. For a RESAS threshold ≥+4, SA was diagnosed with Se=56.0% (0.371-0.733), Sp=98.1% (0.952-0.993), LR+=29.1 (10.4-81.6) in the first cohort and with Se=91.7% (0.646-0.985), Sp=98.3% (0.909-0.997), LR+=53.2 (7.56-373) in the second cohort.
RESAS is a new composite score of four SF variables with excellent performance to predicted SA in acute arthritis population.
根据不同的滑液(SF)变量,建立一种新的用于诊断化脓性关节炎(SA)的预测评分。
首先,我们分析了在一个急性关节炎(<30 天)的单中心队列(n=233)(SYNOLACTATE 队列)中与 SA 诊断相关的不同临床、生物学和 SF 变量(根据 Newman 的标准)。使用多变量分析后,对独立的鉴别变量进行分析,建立一个新的用于预测 SA 的评分(RESAS)。根据其对 SA 诊断的似然比,为评分中的每个变量分配一个值。然后在第一个队列中(内部验证)测试 RESAS 的性能,然后在第二个独立队列(n=70)(外部验证)中进行检查。
经过多变量分析,SF 的四个独立变量被纳入 RESAS:(i)脓性 SF 或白细胞计数≥70,000/mm3;(ii)有无晶体;(iii)乳酸;和(iv)葡萄糖滑膜水平。RESAS 范围在-4 到+13 分之间。RESAS 对预测 SA 的性能非常出色,内部验证的曲线下面积(AUC)为 0.928(0.877-0.980),外部验证的 AUC 为 0.986(0.962-1.00)。对于 RESAS 阈值≥+4,SA 在第一队列中的诊断敏感性为 56.0%(0.371-0.733),特异性为 98.1%(0.952-0.993),LR+=29.1(10.4-81.6),在第二队列中的敏感性为 91.7%(0.646-0.985),特异性为 98.3%(0.909-0.997),LR+=53.2(7.56-373)。
RESAS 是一种新的 SF 变量综合评分,对急性关节炎患者的 SA 诊断具有出色的性能。